Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

John D'Elia, Alissa Segal, George Bayliss, Larry Weinrauch
  • International Journal of Nephrology and Renovascular Disease, June 2017, Dove Medical Press
  • DOI: 10.2147/ijnrd.s135899

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ijnrd.s135899

The following have contributed to this page: Larry Weinrauch

In partnership with: